Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 1,074,696 | reported | 20 Feb 2025 | tx 14+15,275,688−70,452 |
| Kalaris Therapeutics, Inc. | 273,000 | reported | 03 Jul 2023 | tx 2+420,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2025 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,612,032 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,074,696 | 0.00 USD | deriv |
| 15 Jan 2025 | SALE | Adaptimmune Therapeutics PLC | 12,991 | 0.57 USD | |
| 18 Jun 2024 | SALE | Adaptimmune Therapeutics PLC | 24,531 | 0.93 USD | |
| 18 Mar 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,130,832 | 0.00 USD | deriv |
| 18 Mar 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 5,088,864 | 0.00 USD | deriv |
| 03 Jul 2023 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 147,000 | 0.00 USD | |
| 03 Jul 2023 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 273,000 | 0.00 USD | deriv |
| 31 Jan 2023 | SALE | Adaptimmune Therapeutics PLC | 11,890 | 1.87 USD | |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,407,072 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 181,560 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 314,256 | 0.00 USD | deriv |
| 01 Aug 2022 | SALE | Adaptimmune Therapeutics PLC | 21,040 | 1.77 USD | |
| 31 Jan 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 754,200 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 3,376,992 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 335,184 | 0.00 USD | deriv |